At a glance
- Originator Aventis
- Class Small molecules
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cardiovascular disorders; Vascular disorders
Most Recent Events
- 10 May 2000 New profile
- 10 May 2000 Preclinical development for Cardiovascular disorders in United Kingdom (Unknown route)
- 10 May 2000 Preclinical development for Vascular disorders in United Kingdom (Unknown route)